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Since the distinction was made between immunoglobulin-bearing (B) lymphocytes 
that  give  rise  to  antibody  forming  cells  and  thymus  derived,  Thy-l-bearing  (T) 
lymphocytes responsible for a  host of other immune functions, substantial effort has 
been  directed  toward  finding  individual cell surface  markers  that  subdivide  these 
populations. In the mid-1970s, the Lyt-1, Lyt-2, and Lyt-3 antigens were shown  (with 
the assays then available) to be represented exclusively on T  cells (1, 2) and to identify 
functionally distinct  T  cell subpopulations.  Lyt-1  appeared  to  be  restricted  to  the 
helper-amplifier subset, and Lyt-2 and Lyt-3 defined the suppressor-cytotoxic subset 
(3-6). 
The  development  of monoclonal  anti-Lyt  reagents  increased  the  sensitivity with 
which these antigens could be measured and significantly changed the status of the 
Lyt- 1 (Ly- 1) 1 marker: quantitative immunofluorescence studies with the fluorescence- 
activated cell sorter  (FACS)  z revealed that  all Thy-l-bearing cells have  some  Ly-1 
(8); that lower levels of Ly- 1 on cytotoxic-suppressor cells explains the previous failure 
to detect this antigen on the Lyt-2,3 subset with cytotoxic depletion assays; and that 
the frequency of Ly-1 + cells in normal spleen, in fact, is usually slightly greater than 
the frequency of Thy-1 + cells in the same organ  (9). 
Recent studies (10, 11) demonstrating the existence of Ly-l-bearing B cells (Ly-1 B) 
indicate  that  such  cells  account  for  at  least  part  of  this  excess.  These  findings, 
documented by FACS analyses on cell populations from normal animals, are consist- 
ent with a  variety of previous observations: small numbers of Ly-1 + cells are present 
in  B  cell areas of stained tissue sections in  normal  spleen  (8);  certain  mouse  B  cell 
lymphomas synthesize and coexpress Ly-1 and IgM  (7); old NZB mice tend to have 
increased  numbers  of Ly-1  bearing cells  (12)  that  we  have  now  shown  to  be  IgM- 
positive and Thy-1-negative (unpublished observations); human  B  cell chronic lym- 
phocytic leukemias tend to carry IgM and Leu-1  (13), a  human  cell surface molecule 
whose properties are homologous to mouse Ly-1  (14).  Furthermore, a  subpopulation 
* This work was supported in part by grants GM-17367, HD-01287, and CA-04681 from the National 
Institutes of Health. 
:~ Fellow of the American Cancer Society. 
t Several years after its initial description as the first in a series of lymphocyte differentiation  antigens, 
Ly-1 was renamed Lyt-1 to reflect its apparently exclusive expression on T cells. We return here to the 
original usage since this antigen was recently demonstrated  on B cell tumors  (7) and we now report  its 
presence on a subpopulation of normal B ceils. No other cell surface antigen is presently called Ly-l. 
2 Abbreviations used m  this paper:  Bi, biotin;  FACS, fluorescence-activated cell sorter;  FCS, fetal calf 
serum; Fl, fluorescein; Ly-1 B, Ly-l-bearing B cell; PFC, plaque-forming cells; PI, propidium iodide; R1A, 
radioimmunoassay; TR, Texas red. 
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of human B cells has been  shown to carry Leu-1  and IgM  (15, Hardy, R.  R., T. 
Kipps, and L. A. Herzenberg. Manuscript in preparation), and a subpopulation of 
mouse B cells bearing Ly-1 has been shown to play a  role  in regulating antibody 
reponses  (16). 
In this work, we used multiparameter FACS analysis and sorting (10, 17) to define 
the basic characteristics (cell surface markers, frequency, organ location, ontogeny) of 
the Ly-1 B population in normal and immunodefective  mice. In addition, we showed 
that, although sheep  erythrocyte immunization does not generate Ly-1 B cells that 
secrete IgM antibody, the Ly-1 B population in NZB mice secretes large amounts of 
IgM in vitro and accounts for virtually all of the well-studied "spontaneous" IgM 
secretion by spleen cells from these autoimmune mice. 
Materials and Methods 
Mice.  NZB/BinJ, NZB/N,  (NZB  X  NZW)F1, DBA/2,  (CBA/N  ×  DBA)Fx,  and NZB. 
CBA/N  (NZB X-id congenic mice carrying the CBA/N X-linked immunodefieiency) mice 
were  provided  by  Dr.  A.  D.  Steinberg  (National Institute of Arthritis,  Metabolism,  and 
Digestive Diseases, National Institutes of Health). CBA/H-T6 and CBA/N mice provided by 
Dr. J. J. Haaijman (Institute of Experimental Gerontology, TNO, Netherlands) were bred at 
our animal facilities.  BALB/c, SJA/9, and a  C57BL/6 Ig congenic strain (C57BL/6.Igh-a) 
produced by Dr. Noel Warner (Becton-Dickinson Monoclonal Center, Mountain View, CA) 
were also bred in our facility. Nude (nu/nu)  mice were provided by Dr. I. Weissman (Stanford 
University) and Dr. H. Wortis (Tufts Medical School).  MRL/1 mice were provided by Dr. D. 
Wofsy and Dr. W. Seaman (Veteran's Hospital, San Francisco, CA). 
Monoclonal Antibodies.  Reagents used in this study are shown in Table I. 
Fluorochrome Coupling.  Biotin (Bi) and fluorescein (F1) labeling procedures have been de- 
scribed elsewhere  (26, 27). Reagents were conjugated at low label:protein ratios to minimize 
backgrounds. Texas red  (TR)-labeled avidin was prepared by adding 400/zg of TR reagent 
TABLE  I 
Monoclonal Antibody Reagents 
Clone name  Specificity  Isotype  Reference 
53-7.3  Ly-1  Rat IgG2a  18, 19 
53-6.7  Lyt-2  Rat IgG2a  18, 19 
53-2.1  Thy-l.2  Rat IgG2a  18, 19 
331.12  IgM  Rat IgG2a  20 
30-H12  Thy-l.2  Rat IgG2b  18, I9 
30-E2  "E2"  Rat IgG2b  18, 19 
5.3-9.2  ThB  Rat IgG2c  18, 19, 21 
10-4.2  IgD  ~  Mouse IgG2a  22 
MK-D6  Iad  Mouse IgG2a  23 
11-5.2  Ia  k (Ia 2)  Mouse IgG2b  22 
K10.6  Ly- 19  Mouse IgG2b  24 
K7.234  Ly-20  Mouse IgM  25 
Rat monoclonal antibodies were isolated from culture supernatants by goat 
anti-Rat Ig affinity chromatography (18). Mouse monoclonal antibodies were 
purified from ascitic fluid by ammonium sulfate precipitation followed by ion- 
exchange chromatography. 204  "LY-1  B"  CELLS 
(sulfonyl chloride rhodamine derivative; Molecular Probes, Junction City, OR) dissolved in 40 
/~1 of dimethylformamide  to  2  ml  of a  5  mg/ml solution  of avidin  (affinity  purified,  Sigma 
Chemical  Co.,  St.  Louis,  MO.)  in  carbonate  buffer  (pH  9.5).  After  rotating  4  h  at  room 
temperature,  the conjugate was  isolated on  a  10-ml G25  column  and  the concentration  was 
adjusted to  1 mg/ml. The dye-to-protein ratio was determined by measuring the absorbances 
at 280 and 595 nm. All reagents were stored at 4°C with 0. I% sodium azide and deaggregated 
at  100,000 g  in a  Beckman Airfuge (Beckman Instruments,  Inc., Spinco Div., Palo Alto, CA) 
before use. 
Staining for FACS Analysis and Sorting.  Single-cell suspensions  (from which the erythrocytes 
had been lysed by 0.165 M  ammonium chloride) were stained in microtiter wells. For two-color 
staining, 0.5-1  million target cells were put  into the antibody mixture (Fl-antibody A  and Bi- 
antibody B) at a  concentration of one million cells per  100/~1. After 30 min of incubation on 
ice, cells were washed three times. TR-avidin was added,  and cells were further incubated on 
ice for 30 min. During the last 5 min of incubation, propidium iodide was added (50/zl per well 
at  1 /zg/ml) to label dead cells (28).  Cells were then washed as before and analyzed. A  special 
staining medium (deficient RPMI 1640 that does not contain biotin, phenol red, and riboflavin; 
Irvine Scientific, Santa Ana, CA) supplemented with 3% heat-inactivated newborn calf serum, 
10 mM Hepes, 0.1% sodium azide, pH 7.2, was used throughout the procedure. Larger numbers 
of cells (for sorting) were stained in conical centrifuge tubes. 
To  minimize  nonspecific  staining  due  to  Fc  receptor  interactions,  we  deaggregated  the 
staining reagents just before use. We included in all experiments separate control wells in which 
we "stained" with monoclonal antibodies of the same isotype (but of different specificity) as the 
staining  reagent  and  subtracted  this  "background"  frequency from  the overall frequency of 
"positive" cells to determine the actual frequency of stained cells. 
Two-color  Immunofluorescence  Analyses.  To  achieve the level of resolution  required  for these 
studies, we used a  dual-laser FACS equipped with logarithmic amplifiers (for the fluorescence 
channels)  to  measure  light  scatter  (size)  and  the  amounts  of pairs  of fluorochrome-labeled 
monoclonal reagents bound to individual cells (29).  In addition, we used propidium iodide (PI) 
staining (measured with a third fluorescence detection system) to eliminate the few (PI-stained) 
dead ceils that were not rejected by the normal scatter-gating method for excluding dead cells 
(28).  During the analysis, we used a  VAX computer (VAX- 11780;  Digital Equipment  Corp., 
Maynard,  MA) to collect and store individual measurements on 30,000  (live) cells as list mode 
data for later analysis. Thus, we took into account all controls when establishing the boundaries 
("gates")  within  which  a  particular  subpopulation  lies and  when  performing integrations  to 
determine the frequency of cells within the gate. 
Two-color staining data are presented as "contour plots" that  can be viewed as representa- 
tions of three-dimensional  surfaces  in which  the levels of green and  red fluorescence per cell 
define the location of cells on a 64 X 64 grid, and the frequency of cells at each location defines 
the elevation at that location. After smoothing this surface, contour lines are drawn to represent 
equal step changes in the elevation (frequency). 
Immunizations and Antibody  Responses.  Donors were primed with 2 X  l0  s sheep red blood cells 
4  d  before sorting and  assay.  Plaque-forming cell (PFC)  estimations  were performed  by the 
Cunningham  method (30). 
In Vitro Cultures.  Cells were cultured in RPMI  1640 supplemented with 10% fetal calf serum 
at 4 X  106/ml in microtiter wells. Usually, 4 X  10  ~ cells were cultured in 0.1  ml. When smaller 
numbers of cells were cultured, culture volume was decreased proportionately. 
Measurement  of Secreted Immunoglobulins.  Culture supernatants  were cleared by centrifugation 
to avoid contamination by cellular debris, and IgM levels were estimated by a  modified solid- 
phase competitive radioimmunoassay  (RIA)  (31)  using monoclonal anti-IgM antibody coated 
at  10 /tg/ml on  microtiter wells.  20 p,l  of ~z6I-labeled IgM  (HPC-76)  myeloma  protein  at  a 
concentration  of ~0.2  /~g/ml was  mixed with  an  equal  volume of culture  supernatant  fluid 
(appropriately  diluted)  in the coated well and incubated  for  1 h. The amount of IgM present 
in the supernatant  was determined by comparing the counts bound to individual wells with a 
standard  curve generated  with  unlabeled  HPC-76  protein,  serially diluted  in  10%  fetal calf 
serum  (FCS), as a competitive inhibitor in the same assay. This assay detects amounts greater 
than 0,3/~g IgM/ml in culture supernatants. K. HAYAKAWA R.  R.  HARDY, D. R.  PARKS AND L. A.  HERZENBERG  205 
Results 
Cells Bearing Ly-1, IgM, and Other Classic B Cell Markers A re Present in Mouse Spleen.  A 
small subpopulation of spleen cells in all mouse strains carries both IgM and Ly-1 
(Figs.  1 and  2).  These Ly-1  B  cells,  revealed  by two-color FACS  analysis  of cells 
stained with fluorescent monoclonal antibodies, have more surface IgM than most B 
cells and considerably less Ly-1 than most T  cells (i.e., they cluster in the high IgM, 
low Ly-1 region of the contour plot as shown in Fig.  1). They can be demonstrated 
equally well  by staining  with  fluorescein-anti-IgM  and  biotin-anti-Ly-1  plus  TR- 
avidin  (as  shown in Fig.  1)  or with the converse pair of staining reagents  (Fl-anti- 
Ly-1 and Bi-anti-IgM plus TR-avidin) (data not shown), and their frequency is well 
above the consistent "background" staining frequency (0.5-1% of spleen cells) (Fig. 2 
and Table II). 
Ly-1 B carry all differentiation markers found on B cells and none of the differen- 
tiation markers found on T  cells, except Ly-1. Thus, as Table II shows, monoclonal 
antibodies to IgD, Ia, ThB, and some less well-known B cell markers, E2 (19), Ly-19, 
and  Ly-20  (24,  25)  stain  the  same  number  of Ly-l-bearing cells  as  the  anti-IgM 
reagent. Monoclonal antibodies to Thy-1 and Lyt-2, in contrast, do not stain  IgM- 
bearing cells above the typical background  frequency of 0.5-1%.  Preliminary data 
from staining experiments with FACS-isolated Ly-1 B cells (IgM  +, Ly-1 +) are consist- 
ent with these findings. 
Most  mice,  including  nude  (nu/nu)  and  CBA/N  (X-id),  have  about  the  same 
numbers of Ly-1 B in spleen (~ 2% of total spleen cells); however, the Ly-1 B frequency 
in NZB mice is substantially higher (usually >5% of spleen cells) and is even greater 
in the BW hybrid, i.e., (NZB X NZW)F1 (Fig. 2). NZB X-id congenic mice, which fail 
to develop the typical NZB autoimmunity, and MRL mice, which develop a different 
type of autoimmune disease than NZB (32), apparently have normal numbers of Ly- 
1 B (Fig. 2 and preliminary observations, A. D. Steinberg and the authors). 
In all mice tested (including X-id, nude, NZB, and BW hybrids), Ly- 1 B are clearly 
detectable in spleen but essentially undetectable in lymph nodes, bone marrow, and 
thymus, i.e., the Ly-1  B  frequency in  the latter organs  is equal  to or barely above 
background staining frequency (Table III). The contrast between Ly-1 B represen- 
tation  in  spleen and  lymph  node is  particularly dramatic  in  NZB  and  BW mice, 
where there are 5 to 10 times as many Ly-i B detectable in spleen as in lymph node. 
In addition, Ly-1 B can sometimes be found in peripheral blood, particularly in NZB 
and BW mice. 
Ly-1 B Appear Early during Ontogeny.  The appearance of Ly-1 B coincides with the 
appearance of the first IgD-bearing B cells detectable in neonatal spleen; however, 
unlike  other  B  (or  T)  lymphocyte subpopulations,  the  frequency of the  Ly-I  B 
subpopulation  rapidly  reaches  adult  levels.  Thus,  the  proportion  of Ly-1  B  cells 
relative to other lymphocyte populations in the spleen decreases markedly with age 
(as  these  other  populations  reach  mature  levels),  and  Ly-1  B  become  a  minor 
subpopulation  in the adult. This ontogenic pattern is similar in BALB/c and NZB 
mice, even though NZB have many more Ly-1 B (Table IV). 
Ly-1 B in the neonate have the same properties as Ly-1 B in the adult with regard 
to expression of surface markers, light scatter, and organ location (data not shown). 
Ly-1 B  Are in B  Lymphocyte Subpopulation IlL  We recently resolved splenic B cells 
into three subpopulations (I-III) on the basis of the correlated expression of IgM and o
 
_
_
-
-
 
I
-
 
N
Z
B
 
s
p
l
e
e
n
 
.
J
 
I
 
,
t
 
1
1
 
t
O
 
I
m
 
I
 
g
M
/
C
e
l
 
I
 
-
 
N
Z
B
 
s
p
l
e
e
n
 
[
 
'
"
~
'
"
'
I
 
'
,
,
I
 
.
.
.
.
.
.
.
 
I
 
.
.
.
.
.
.
.
 
1
 
.
.
.
.
 
!
 
I
g
M
/
C
e
l
l
 
F
i
e
.
 
1
.
 
R
e
s
o
l
u
t
i
o
n
 
o
f
 
a
 
p
o
p
u
l
a
t
i
o
n
 
o
f
 
L
y
-
l
-
p
o
s
i
t
i
v
e
 
B
 
c
e
l
l
s
 
(
I
g
M
 
b
r
i
g
h
t
,
 
L
y
-
1
 
d
u
l
l
)
 
b
y
 
t
w
o
-
c
o
l
o
r
 
i
m
m
u
n
o
f
l
u
o
r
e
s
c
e
n
c
e
.
 
S
p
l
e
e
n
 
c
e
l
l
s
 
f
r
o
m
 
a
 
2
-
r
a
n
-
o
l
d
 
N
Z
B
 
m
o
u
s
e
 
w
e
r
e
 
c
o
s
t
a
i
n
e
d
 
w
i
t
h
 
F
l
-
a
n
t
i
 
I
g
M
 
a
n
d
 
e
i
t
h
e
r
 
B
i
-
a
n
t
i
-
L
y
-
1
,
 
B
i
-
a
n
t
i
-
T
h
y
-
1
 
o
r
 
B
i
-
a
n
t
i
-
 
L
y
t
-
2
 
+
 
T
R
-
a
v
i
d
i
n
.
 
T
h
e
 
i
n
t
e
g
r
a
t
i
o
n
 
b
o
u
n
d
a
r
i
e
s
 
u
s
e
d
 
t
o
 
d
e
t
e
r
m
i
n
e
 
L
y
-
1
 
B
 
f
r
e
-
 
s
 
N
Z
B
 
s
p
l
e
e
n
 
-
I
.
 
[
 
~
 
D
~
I
.
.
 
j
 
i
 
i
l
l
 
.
.
.
.
.
.
.
 
1
 
.
.
.
.
.
.
 
~
l
 
.
.
.
.
 
I
 
.
l
 
I
~
 
1
9
 
t
I
N
 
I
g
M
/
C
e
l
l
 
q
u
e
n
c
i
e
s
 
r
e
p
o
r
t
e
d
 
i
n
 
t
h
i
s
 
p
u
b
l
i
c
a
t
i
o
n
 
a
r
e
 
d
r
a
w
n
 
o
n
t
o
 
t
h
e
 
c
o
n
t
o
u
r
 
p
l
o
t
.
 
I
n
 
e
a
c
h
 
e
x
p
e
r
i
m
e
n
t
,
 
f
r
e
q
u
e
n
c
y
 
o
f
 
L
y
-
1
 
B
 
r
e
p
o
r
t
 
i
s
 
c
o
r
r
e
c
t
e
d
 
b
y
 
s
u
b
t
r
a
c
t
i
n
g
 
t
h
e
 
"
b
a
c
k
g
r
o
u
n
d
"
 
s
t
a
i
n
i
n
g
 
f
r
e
q
u
e
n
c
y
 
(
w
i
t
h
i
n
 
t
h
e
 
i
n
t
e
g
r
a
t
i
o
n
 
b
o
u
n
d
a
r
i
e
s
 
s
h
o
w
n
)
 
o
f
 
a
n
 
a
l
i
q
u
o
t
 
s
t
a
i
n
e
d
 
w
i
t
h
 
a
n
t
i
-
I
g
M
 
a
n
d
 
a
n
t
i
-
T
h
y
-
l
 
(
s
e
e
 
M
a
t
e
r
i
a
l
s
 
a
n
d
 
M
e
t
h
o
d
s
)
.
 
r
~
 
,
<
 
f
3
 
t
"
 K.  HAYAKAWA,  R.  R.  HARDY,  D.  R.  PARKS  AND  L.  A.  HERZENBERG  207 
Strains 
Nor•al  •ice 
Balb/c,  DBA/2 
CBA, SJA, BAB/14 
C$TBL/6-1gha 
Immunodeficient  mice 
CBA/N, NZB.CBA/N 
(CBA/N  X DBA/2)F! 
CBA nu/nu 
Balb/c  nu/nu 
Autoimmune  •ice 
NZB  (NZB/BinJ,  NZB/N) 
(NZB  X NZW)F  I 
MRL/I 
tyl  B in  spleen  (  Z  ) 
1  2  3  4  5  6  7  8  g  i0  ii  12  13  14  15 
o.  1..:IX~  .. 
~lPq~ o  •  o  go• 
•  .•  .o: .... :,  -:.  • 
•  •  •  •  •  • 
Fic.  2.  Ly  1 B are present in all strains of mice tested and elevated in NZB and related strains. 
Spleen  cells  from  2-  to  3-mo-old  mice  were  stained  and  frequencies of Ly-1  B  determined  as 
described in Fig.  1 
TABLE  II 
Ly-1 B Express B Cell Markers 
Determinants detected by staining 
reagents 
Positive cells in spleen 
NZB  BALB/c  SJA 
Experiment 1 
% 
IgM  49  59  43 
Ly- 19 (polymorphic)  41  54  0 
Ly-20  (polymorphic)  0  54  0 
Ly-1 and IgM  8  3  4 
Ly-1 and Ly-L9  7  3  0 
Ly-1 and Ly-20  0  2  0 
Experiment 2  Ly-1 and IgM  4  ND~  ND 
Ly-1 and Ia  d  5  ND  ND 
Ly-1 and IgD  a  4  ND  ND 
Ly-1 and E2  4  ND  ND 
Ly-1 and ThB  6  ND  ND 
Ly-2 and IgM  0.5* 
Thy- 1 and IgM  1" 
* Staining with these reagents is defined as background and subtracted from 
all  other  frequencies  reported  (see  Materials  and  Methods).  Background 
values for reagents detecting polymorphic determinants were obtained by 
staining the genetically negative controls (~2%). 
:~ Not determined. 
IgD  (10,  17).  Subpopulation  III,  like Ly-1  B, has high levels of surface IgM  and  low 
to intermediate  levels of surface IgD. Its levels of other B  cell markers match  the levels 
found on Ly-1  B  and  it, too,  is found  almost exclusively in spleen  (Fig.  3). 
Ly-1  B  frequencies  approximate  B  cell subpopulation  III frequencies  in all mouse 208  "LY-1  B"  CELLS 
TABLE  III 
Ly-I B Reside Primarily in Spleen 
NZB cells* carrying 
IgM  Ly- 1  IgM and Ly- ! 
(Ly-1 B) 
% 
Spleen  55  48  5 
Peripheral  blood  (lympho-  23  58  0:~ 
cyte)  23  79  0 
Lymph node  13  1  0 
Bone marrow  2  98  0 
Thymus 
* Average frequencies shown here for 2-mo-old NZB mice are representative 
of frequencies measured for adult mice in this strain. Ly-1 B frequencies in 
other mouse strains are roughly half as high. 
~: 1-2% Ly-1 B occasionally detectable. 
TABLE IV 
Ly-1 B Appear Early in Ontogeny 
Spleen cells at various ages 
Surface  NZB mice  BALB/c mice  marker(s) on cells 
5 d  2 wk  4 wk  8 wk  5 d  2 wk  4 wk  8 wk 
% 
IgM  10  30  56  53  15  17  48  52 
Ly-1  9  16  43  57  8  13  34  41 
IgM and Ly-  1"  3  4  7  7  2  1  1  1 
(30)  (13)  (13)  (13)  (13)  (6)  (2)  (2) 
* Ly-1 B in spleen (%) and, shown in parentheses, Ly-1 B in splenic lgM-bearing population (%). 
strains except those with  the X-linked immunodeficiency  (X-id)  defect  (33)  (Table 
V). In NZB, the increase in Ly-1  B  frequency translates to a  very high frequency of 
subpopulation III, making this normally small subpopulation easily visible in FACS 
analysis (Fig. 3).  X-id mice show a  similar elevation in subpopulation III; however, 
this  elevation  is not  accompanied  by an  increase  in  Ly-1  B  frequency.  Thus,  X-id 
mice  have  relatively  large  numbers  of  Ly-l-negative  cells  in  subpopulation  III, 
suggesting that, although subpopulation III in normal animals consists largely of Ly- 
1 B, it may also contain some cells that do not have surface Ly-1. 
FACS Isolation  of Ly-1  B.  Classic  methods  that  enrich  for  Ig-positive  (B)  cells 
(killing or  panning with  anti-Thy-1,  isolating nylon-adherent  cells), also enrich  for 
Ly-1 B. None of these T-depletion methods, however, substantially alters the frequency 
of Ly-1  B  relative to the frequency of other B  cell subpopulations  (data not shown). 
Thus,  they offer little advantage for functional  studies aimed at  identifying unique 
role(s) played by Ly-1 B. 
Using the FACS to sort spleen cells that costain with anti-IgM and anti-Ly-1 yields 
suspensions  in  which  Ly-1  B  represent  80-90%  of the  sorted cells.  Ly-l-negative B 
cells constitute the major contamination;  however, a  small number of T  cells (1-2%) 
are  often  present.  Histological staining  (Wright-Giemsa)  of FACS-isolated Ly-1  B B
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TADLE  V 
B Cell Subpopulation III and Ly-1 B Frequencies Coincide Except in CBA/N 
Mouse strain 
(X-id) Mice 
Spleen cells 
III*  Ly- 1 B 
% 
Balb/c  3  3 
DBA/2  4  3 
C57BL/6.Igh"  4  5 
CBA  2  2 
SJA  2  3 
NZB  8  10 
(NZB x NZW)F1  I 1  15 
CBA/N  12  2 
* Subpopu[ation IlI, defined by large amounts of surface IgM and relatively 
small amounts of surface IgD (see Fig. 3). 
from  either  BALB/c  or  NZB  mice  reveals  a  population  consisting  mainly  of 
"lymphoblastoid" cells whose appearance contrasts sharply with  that  of the  typical 
small  "resting" lymphocytes that  constitute  the  majority of the  B  cells in  BALB/c 
spleen (Fig. 4). 
Ly-1 B from NZB Mice Spontaneously Secrete IgM In  Vitro and Are Distinct from  Antigen- 
stimulated IgM-secreting Cells.  FACS-sorted Ly-1 B from NZB mice secrete ~40 times 
as much IgM as sorted Ly-l B  from BALB/c mice when cultured  in the absence of 
added  antigens  or mitogens  (Table VI).  Ly-l-negative B  cells,  in  contrast,  do  not 
secrete detectable levels of IgM, except when sorted from recently immunized animals 
(Tables VI and VII). Thus,  the spontaneous IgM secretion by spleen cells cultured 
from nonimmunized  NZB mice is due entirely to the activity of the Ly-1 B  cells in 
these mice. 
4 d  after immunization with sheep erythrocytes (SRBC), in contrast, sorted Ly-1- 
negative  cells  from  NZB  spleen  contain  "direct"  plaque-forming  ceils  (PFC)  that 
secrete IgM antibody (Table VII). The small number of PFC recovered in the sorted 
Ly-1 B population is proportional to the contamination of this sorted population by 
Ly-l-negative B cells. Thus, although  Ly-1  B  from NZB mice secrete IgM, they do 
not include the IgM-secreting cells (PFC)  generated in the response to SRBC. 
The IgM-secreting PFC  in  the  Ly-l-negative population  increase  the  amount  of 
IgM  produced  by  this  population  in  comparison  with  the  sorted  Ly-l-negative 
population  from nonimmunized  animals.  Ly-1  B  IgM secretion,  however,  does  not 
change after immunization  (Table VII). Thus, IgM-secreting Ly-1 B are completely 
distinct from the PFC generated by immunization with SRBC. 
Ly-l Is More Firmly Bound to Ly-l B  Than IgM.  Most of the IgM on Ly- I Bcanbe 
readily removed  ("stripped")  after staining with  anti-IgM by culturing  the stained 
cells  for  several  hours.  Ly-1,  however,  strips  off only  minimally  under  the  same 
conditions.  Thus, when FACS-isolated  Ly-1 B  that were stained  before sorting with 
Fl-anti-IgM and Bi-anti-Ly-1 plus TR-avidin are cultured overnight, virtually all of 
the IgM-associated (green)  fluorescence disappears from the cells, while most of the 
Ly-1 associated (red)  fluorescence remains (Fig.  5).  Ly-1 B stained with the converse 
pair  of reagents  (green  Ly-1  and  red  IgM)  yield  the  same  results.  Furthermore, K.  HAYAKAWA,  R.  R.  HARDY,  D.  R.  PARKS  AND  L.  A.  HERZENBERG  211 
Fro.  4.  Ly  1 B  appear  to  be  "lymphoblastoid" cells.  Ly-1  B  and  other  (Ly-l-negative)  B  cells 
sorted from a Thy-l-depleted NZB spleen cell suspension stained with Fl-anti-IgM and Bi-anti-Ly- 
1 +  TR-avidin. Sorted  cells were smeared onto glass slides, fixed, and processed by the standard 
Wright-Giemsa staining procedure. 
TABLE gI 
NZB Mice Have Ly-I B  That Secrete IgM 
IgM secreted in vitro* 
Mouse  Cultured spleen cell  4 h  6 d 
strain  population 
per well  per l0  s  per well  per 10  ~ 
#g 
NZB  Unseparated spleen  0.3  0.8  3.1  7.8 
FACS-sorted cells 
Ly-1 B  0.3  0.8  15.0  37.5 
Other IgM  + B  <0.03  <0.08  0.4  1.0 
Balb/c  Unseparated spleen  <0.03  <0.08  <0.1  <0,3 
FACS-isolated cells 
Ly- 1 B  <0.03  <0.08  0.4  1.0 
Other IgM  + B  <0.03  <0.08  <0.1  <0.3 
* IgM secreted during the indicated culture period.  4  ×  10  s cells per well cultured for the 
indicated  time in  0.1  ml  RPMI  1640 +  10%  FCS.  No exogeneous antigens or mitogens 
were added. IgM in culture supernatant was measured by RIA. Sorted fractions represent 
8,  17, 4, and 33% of spleen, respectively. 212  "LY-1  B"  CELLS 
TABLE VII 
Antigen-stimulated  IgM-secreting  Cells (PFC  )  Do Not Carry Ly-1 
Spleen cell populations from 
SRBC-primed NZB~ 
PFG* 
per chamber  per  I06 
Secreted  Ly-1 B fre- 
IgM* per 106  quency* 
number  Ixg  % 
Stained unseparated spleen  83  553  12.7  5 
Sorted cells 
All IgM  +  138  920  14.0  10 
IgM  +, Ly-1 + (Ly-1 B)  19  127  30.7  85 
IgM  +, Ly-1-  103  687  12.0  <I 
IgM  , Ly-I + (T cells)  0  <7  <0.2  <1 
* Half of the cells in the sorted population were cultured at  1.5 ×  10  s cells per well in 
0.04 ml RPMI  1640 +  10%  FCS  for 6  d, and the amount of secreted IgM in the 
supernatant was measured by RIA. The remaining cells were used immediately to 
estimate  direct  PFC  (anti-SRBC)  in  the  Cunningham  assay  (1.5  X  10  ~  cells/ 
chamber). Frequency of Ly-1 B was determined by reanalysis of sorted cells. 
:~ 2-mo-old NZB mice immunized with 2  ×  108 SRBC  intraperitoneally 4  d  before 
sorting. Sorted fractions represent 51, 11,  14, and 26% of spleen, respectively. 
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FIG.  5.  Ly-I  remains firmly bound  to  Ly-I  B  cells after  24  h  in  culture.  An aliquot  of FACS- 
isolated Ly-1 B  (costained with Fl-anti-IgM and Bi-anti-Ly-1 +  TR-avidin) from NZB spleen was 
analyzed immediately after sorting. The remaining Ly~l  B  were cultured in  RPMI  1640  +  10% 
FCS  for 24 h. An aliquot  of these cells was then incubated with TR-avidin alone  (control),  and 
another aliquot was restained with Fl-anti-IgM and Bi-anti-Ly-1 +  TR-avidin. Staining histograms 
show the immediate reanalysis of the sorted population  (0 h), the residual staining after 24 h  in 
culture (24 h), and the amount of reexpression found by restaining this 24-h culture (24 h  restain). 
incubating stained and sorted Ly-1 B (before culture) with "second-step" anti-rat-Ig 
antibodies, which bind to the monoclonal anti-Ly- 1 reagent and should thus facilitate 
stripping, fails to remove Ly-1. Thus,  Ly-1 specifically remains on the cells, despite 
the removal of most of the IgM under the same conditions. 
The difficulty in stripping Ly- l poses a problem for attempts to directly demonstrate 
that Ly-1 B express, rather than acquire, Ly-1. Regrowth experiments in which sorted 
Ly-1 B are cultured after stripping show that surface IgM reappears and reaches its 
original level within 24 h (Fig. 5); however, because the original Ly-1-staining reagent 
remains  associated  with  the  cells,  the  increase  in  Ly-1  observed after culture  and 
restaining is difficult to interpret. This increase could be due (a) to newly synthesized 
Ly-1;  (b)  to  unmasking  of previously present  Ly-1  molecules;  or  (c)  to  a  lack  of 
saturation of all of the Ly-1 on the cells during the initial staining. Thus, although we K. HAYAKAWA, R.  R.  HARDY, D.  R.  PARKS AND L. A. HERZENBERG  213 
can show that Ly-1 B are clearly B cells in that they resynthesize their IgM receptors, 
we cannot state that these cells have synthesized the Ly-1 they carry. 
These findings with splenic Ly- 1 B recall evidence from similar studies with a B cell 
lymphoma that  carries both  Ly-1  and  IgM  (7).  The Ly-1  on  this  lymphoma was 
shown to be a normal membrane component, internally synthesized and indistinguish- 
able biochemically from the Ly-1 on T  cells; however, it clearly remains associated 
with the cell membrane under conditions that readily remove IgM. Thus, our failure 
to strip Ly-1 from Ly-1 B appears to reflect the normal behavior of the Ly-1 molecule 
when expressed on B cell membranes. 
Discussion 
Ly-1 B first attracted attention (10,  11) because they carry surface molecules that 
were believed to be present only on T  cells.  However, as we have now shown,  the 
presence of  surface Ly- 1 represents only one of  a set of  equally surprising characteristics 
that  distinguish  these cells from the typical B  cells present  in peripheral lymphoid 
organs. In essence, Ly-1 B constitute a B cell subpopulation different enough to raise 
the possibility that it might represent a distinct lymphocyte lineage separated quite 
early in evolutionary time. 
We mainly used normal mice to define the characteristics of this subpopulation, 
since it constitutes a virtually invariant component of the overall B cell population in 
such  mice.  We  completed this  characterization,  however,  with  data  derived  from 
studies with three types of immunodefective animals:  nude (nu/nu)  mice that  have 
few (if any) mature T  cells; X-linked immunodeficiency (X-id) mice such as CBA/N 
that have only two of the three B cell subpopulations found in normal mice (I 7) (and 
which show other B  cell developmental abnormalities  mentioned here);  and  NZB- 
related autoimmune mice that produce large amounts of IgM autoantibodies as part 
of a characteristic disease pattern (34-37). 
Thus we show (a) that Ly-1 B carry all of the classic B cell differentiation markers 
(IgM, IgD, Ia, and ThB) and none of the classic T cell markers, except Ly- 1;  (b) that 
these cells nevertheless have more IgM,  less  IgD, more ThB, and somewhat  less  Ia 
than most B cells; (c) that they are present almost exclusively in spleen; and (d) that 
they  are  well  represented  in  neonatal  animals  but  constitute  only  a  very  small 
proportion of the overall splenic B  cell population  in  adults.  In  normal  mice, this 
subpopulation essentially coincides with B cell subpopulation III (the least frequent 
of three  subpopulations  that  we  recently defined  according to  correlations in  the 
quantitative expression of IgM and IgD)  (10,  17). 
Studies with nude mice add two key points. First, the presence of normal numbers 
ofLy-1 B in these genetically T-deficient animals severs Ly-1 B from the T cell lineage 
(which requires a functional thymus for development). Thus, Ly-1 B emerge as a true 
B cell subpopulation rather than a subpopulation, that is, in some way "part T  and 
part B." Second, the presence of normal amounts of Ly-1 on the Ly-1 B subpopulation 
in nude mice strongly suggests that Ly-1 B produce rather than acquire their surface 
Ly-1, since there are very few T  cells to serve as Ly-1 "donors" in nude animals. 
Gene(s)  controlling the  X-linked  immunodeficiency in CBA/N  (X-id)  mice  (33, 
36),  which  deplete the normally predominant  B  cell subpopulation  I  and  increase 
subpopulations  II  and  III  (10,  17),  leave  the  Ly-1  B  population  at  its  normal 214  "LY-1 B" CELLS 
frequency. Since Ly-1 B normally comprise all or nearly all of the cells in subpopu- 
lation III, these studies also show that the X-id defect causes a selective expansion of 
a  Ly-l-negative component  of B  cell  subpopulation  III  that  is  either  minimally 
represented or completely missing in normal animals. 
Gene(s) in the autoimmune NZB mouse strain (38), in contrast, selectively increase 
Ly-1 B  frequencies.  From neonatal life onward,  NZB  mice have abnormally large 
numbers  of Ly-1  B  (and  correspondingly increased  numbers of subpopulation  III 
cells).  The  presence of these  cells,  which  have large  amounts  of surface  IgM  and 
relatively small amounts of surface IgD, accounts for previous reports indicating that 
NZB B  cells  (studied as a  bulk population)  have abnormally high  IgM/IgD ratios 
(39). 
The enlarged Ly-1 B population in NZB mice appears homogeneous and cannot 
be  distinguished  from  normal  Ly-1  B  by  the  analytic  criteria  used  here  (surface 
marker distribution, light scatter, organ location); however, functional studies show 
that it contains unique cells missing or minimally represented in normal mice. Unlike 
normal Ly-1 B, these cells (isolated from unimmunized animals) spontaneously secrete 
large amounts of IgM when cultured in the absence of added stimulants (mitogens or 
antigens). 
Antigenic stimulation generates antibody-producing cells that also secrete IgM in 
vitro, e.g., large numbers of IgM-secreting ("direct") PFC appear in the spleen after 
immunization with  SRBC.  These normal  IgM-secreting cells,  however, are clearly 
Ly-1 negative and thus distinct from the atypical IgM-secreting Ly-1 B population in 
NZB mice. This distinction is further demonstrated by the fact that Ly- 1 B frequencies 
in NZB (and normal) mice remain constant after SRBC immunization, whereas PFC 
frequencies rise dramatically; in addition, sorted Ly-1 B secrete equivalent amounts 
of IgM  whether  taken  from  SRBC-immunized  or  nonimmunized  NZB  animals, 
whereas  Ly-l-negative  populations  secrete  detectable  IgM  only  if  isolated  from 
recently immunized donors. 
Since SRBC immunization may not stimulate all B cell subpopulations capable of 
responding to other kinds of antigens  (40,  41), the Ly-1 B population could contain 
a  special subset  of normal, antigen-stimulated  IgM-secreting cells.  But  even if this 
were the case, our data still clearly demonstrate that the IgM secretion obtained from 
NZB  spleen  derives  from  a  unique  population  of  (Ly-1  B)  cells  rather  than,  as 
previously  suggested  (42),  from  excessive  numbers  of normal  IgM-secreting  cells 
generated  by the  "hyperactivity" of the  predominant  B  celI  populations  in  NZB. 
Earlier studies (35) also attributed spontaneous NZB IgM secretion to atypical cells; 
however,  this  conclusion was  based  on  kinetic  evidence indicating  that  the  IgM- 
secreting cells in NZB spleen differ from NZB splenic precursor B cells that respond 
normally to in vitro LPS stimulation  (by differentiating to IgM-secreting cells after 
several days in culture). 
The elevated Ly-1  B  frequencies in  NZB mice reported here have been  demon- 
strated  previously  (10,  11). Similarly,  as  indicated  above,  the  spontaneous  IgM 
secretion by cultured NZB spleen cells was described years ago as one of the complex 
phenomena that occur in these autoimmune mice (34-36). Our studies confirm and 
extend these findings. In addition, however, we make a key connection by demonstrat- 
ing that the IgM secretion is due to an aberrant, IgM-secreting B cell population that 
exists within the enlarged Ly-1 B subpopulation in these mice. K. HAYAKAWA, R.  R.  HARDY, D.  R.  PARKS AND L. A.  HERZENBERG  215 
The NZB gene(s) that cause the enlargement of this population does not necessarily 
influence  the  representation  of normal  Ly-1  B,  either  in  NZB  or  in  other  mouse 
strains.  The  proportion  of atypical  cells  in  the  NZB  Ly-1  B  population  and  the 
relationship of these cells to normal Ly-1 B has yet to be determined. Thus, Ly-1 B 
cells such as those in BALB/c mice could be present at the normal frequency in NZB 
mice and in fact, could be completely unrelated to the atypical IgM-secreting Ly-1 B 
in these mice. 
Normal Ly- 1 B appear to have evolved in response to strong selective pressures that 
permit little variation from animal to animal. All mouse strains (except perhaps NZB) 
have comparable numbers of these cells, which characteristically reside almost exclu- 
sively in the spleen and emerge early in ontogeny as a major lymphocyte population 
that decreases in relative frequency as other lymphocyte populations approach their 
adult levels. The constancy of these properties suggests that Ly-1 B play one or more 
key functional roles (as yet undefined) in the immune system. 
A  murine  population  of normal  antigen-specific  (B')  cells  lacking  Thy-1  and 
(apparently) carrying both Ly-1 and IgM has been shown to augment in vitro IgG 
antibody responses in the presence of carrier-specific help (16). Our data demonstrat- 
ing Ia on Ly-1 B would appear to distinguish  Ly-1 B  from B' cells  (which are not 
killed by anti-la plus complement); however, preliminary observations indicate that 
Ly-1 B are not easily depleted by cytotoxic treatment with anti-Ia. Thus, the studies 
with B' cells suggest that the normal Ly-1 B subpopulation may contain cells active 
in the regulation of antibody responses mounted by other B cells. 
Summary 
A small subpopulation of normal murine splenic B cells carrying all of the classic 
B cells markers  (IgM, IgD, Ia, and ThB)  also carries Ly-1, one of the major T  cell 
surface  molecules.  This  "Ly-1  B"  subpopulation  (identified  and  characterized  by 
multiparameter FACS analyses) consists of relatively large, high-IgM/low-IgD/low- 
Ly-1  lymphocytes that  represent  ~2%  of the  spleen  cells  in  normal  animals  and, 
generally, 5-10%  of spleen cells in  NZB  mice.  Ly-I B  are el.early detectable in  all 
normal mouse strains tested as well as NZB, CBA/N, other X-id mice and nude (nu/ 
nu)  mice. They are found primarily in the spleen;  are either absent or very poorly 
represented in lymph node, bone marrow, and thymus; appear early during ontogeny; 
and comprise about a  third of the small number of lymphocytes present in 5-d-old 
mice. 
NZB  and  (NZB  ×  NZW)F1  mice have more Ly-I B  than  all other strains and, 
furthermore, have a unique Ly-1 B population that secretes IgM when cultured under 
usual conditions in the absence of added antigen. The IgM secretion by these Ly-1 B 
cells accounts for the previously reported "spontaneous" IgM secretion by NZB spleen 
cells in culture.  Studies with  FACS-sorted cells show that  the presence of Ly-1  on 
these IgM-secreting cells distinguishes them from the (Ly-1 negative) IgM-secreting 
"direct" plaque-forming cells generated in  NZB  mice after stimulation  with  sheep 
erythrocytes. 
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